Recurrent Endometrial Serous Adenocarcinoma

Explore clinical trials studying Recurrent Endometrial Serous Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Recurrent Endometrial Serous Adenocarcinoma trial results

Recruiting

NCT05231122

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +29 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

M D Anderson Cancer Center Houston, Texas, United States

Completed

NCT03325634

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
Locations: University of Colorado Hospital Aurora, Colorado, United States

Active, Not Recruiting

NCT03914612

Conditions: Carcinosarcoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, +30 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Alaska Women's Cancer Care Anchorage, Alaska, United States

CTCA at Western Regional Medical Center Goodyear, Arizona, United States

NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States

View all 397 locations

Active, Not Recruiting

NCT03120624

Conditions: Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +19 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

Active, Not Recruiting

NCT05870761

Conditions: Recurrent Endometrial Serous Adenocarcinoma
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States